Eric Venker, President & Immunovant CEO at Roivant Sciences Ltd. (ROIV), sold 200,000 shares at $33.05 ($6.6M) on 2026-06-24, disclosed to the SEC on 2026-06-26.
Seasonal sale ($6.6M) by President & Immunovant CEO — this insider has traded ROIV in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.05 | 153,766 | $5.1M | 76.6% |
| 2 | $33.51 | 46,234 | $1.5M | 23.4% |
| Total | $33.16 avg | 200,000 | $6.6M | 100% |
| Filing → |
| ROIV | SELL | 2026-09-01 | $7.2M | — | Filing → |
| ROIV | SELL | 2026-07-29 | $7.0M | — | Filing → |
| IMVT | SELL | 2026-07-06 | $119K | — | Filing → |